Using Nominal Group Technique With Human-Centered Design to Inform Preimplementation Planning for Combined Rapid-Start Initiation of Antiretroviral and Opioid Agonist Therapies in People Who Inject Drugs With HIV in Ukraine.

Saved in:
Bibliographic Details
Title: Using Nominal Group Technique With Human-Centered Design to Inform Preimplementation Planning for Combined Rapid-Start Initiation of Antiretroviral and Opioid Agonist Therapies in People Who Inject Drugs With HIV in Ukraine.
Authors: Johnson AE; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA., Tate M; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA., Filippovych M; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA., Bromberg DJ; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA., Kiriazova T; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA., Madden LM; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA., Dvoriak S; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA., Altice FL; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.
Source: The Journal of the Association of Nurses in AIDS Care : JANAC [J Assoc Nurses AIDS Care] 2026 May-Jun 01; Vol. 37 (3), pp. 321-336.
Publication Type: Journal Article
Journal Info: Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 9111870 Publication Model: Print Cited Medium: Internet ISSN: 1552-6917 (Electronic) Linking ISSN: 10553290 NLM ISO Abbreviation: J Assoc Nurses AIDS Care Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42043845
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Using Nominal Group Technique With Human-Centered Design to Inform Preimplementation Planning for Combined Rapid-Start Initiation of Antiretroviral and Opioid Agonist Therapies in People Who Inject Drugs With HIV in Ukraine.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Johnson+AE%22">Johnson AE</searchLink>; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Tate+M%22">Tate M</searchLink>; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Filippovych+M%22">Filippovych M</searchLink>; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Bromberg+DJ%22">Bromberg DJ</searchLink>; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Kiriazova+T%22">Kiriazova T</searchLink>; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Madden+LM%22">Madden LM</searchLink>; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Dvoriak+S%22">Dvoriak S</searchLink>; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Altice+FL%22">Altice FL</searchLink>; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229111870%22">The Journal of the Association of Nurses in AIDS Care : JANAC</searchLink> [J Assoc Nurses AIDS Care] 2026 May-Jun 01; Vol. 37 (3), pp. 321-336.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%22">Wolters Kluwer Health </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9111870 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1552-6917 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210553290%22">10553290 </searchLink><i>NLM ISO Abbreviation: </i>J Assoc Nurses AIDS Care <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42043845
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1097/JNC.0000000000000640
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 321
    Titles:
      – TitleFull: Using Nominal Group Technique With Human-Centered Design to Inform Preimplementation Planning for Combined Rapid-Start Initiation of Antiretroviral and Opioid Agonist Therapies in People Who Inject Drugs With HIV in Ukraine.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Johnson AE
      – PersonEntity:
          Name:
            NameFull: Tate M
      – PersonEntity:
          Name:
            NameFull: Filippovych M
      – PersonEntity:
          Name:
            NameFull: Bromberg DJ
      – PersonEntity:
          Name:
            NameFull: Kiriazova T
      – PersonEntity:
          Name:
            NameFull: Madden LM
      – PersonEntity:
          Name:
            NameFull: Dvoriak S
      – PersonEntity:
          Name:
            NameFull: Altice FL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May-Jun 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1552-6917
          Numbering:
            – Type: volume
              Value: 37
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: The Journal of the Association of Nurses in AIDS Care : JANAC
              Type: main
ResultId 1